Literature DB >> 30997187

The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker.

Kazutoshi Hamanaka1, Kentaro Miura2, Tsutomu Koyama1, Shunichiro Matsuoka1, Tetsu Takeda1, Kyoko Yamada1, Akira Hyogotani1.   

Abstract

Entities:  

Year:  2019        PMID： 30997187      PMCID： PMC6424753          DOI： 10.21037/jtd.2019.01.83

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  2 in total

1.  Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy.

Authors:  Shu-Qi Li; Xia-Hong You; Fan Sun; Zi-Jin Xia; Zhou Fang; Wei Wang; Yao Li; Xiao-Zhong Wang; Hou-Qun Ying
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy.

Authors:  Zhiyuan Zheng; Donghong Lin; Qiaoqian Chen; Bin Zheng; Mingqiang Liang; Chun Chen; Wei Zheng
Journal:  Cancer Manag Res       Date:  2021-03-12       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.